Key result
R-CHOP response links to greater increases in high-SUV epicardial and orbital adipose tissue volumes.
Why the study?
Brown adipose tissue possesses anti-cancer potential, and practical biomarkers for non-Hodgkin’s lymphoma based on metabolic activity of adipose tissue were not established.
Do changes in high-SUV epicardial and orbital adipose tissue volumes correlate with treatment response to R-CHOP in patients with non-Hodgkin's lymphoma?
Observational (n=20)
Do changes in high-SUV epicardial and orbital adipose tissue volumes correlate with treatment response to R-CHOP in patients with non-Hodgkin's lymphoma?
Changes in high-SUV epicardial and orbital adipose tissue volumes on PET/CT may serve as a prognostic biomarker for treatment response in non-Hodgkin's lymphoma.
Answers are grounded in this paper and cite their sources.
Adipose tissue activity on PET/CT may inform NHL biomarkers; leaves open prospective validation before clinical use.
Background: A regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment for non-Hodgkin’s lymphoma. Brown adipose tissue possesses anti-cancer potential. This study aimed to explore practical biomarkers for non-Hodgkin’s lymphoma by analyzing the metabolic activity of adipose tissue. Methods: Twenty patients who received R-CHOP for non-Hodgkin’s lymphoma were reviewed. Positron emission tomography/computed tomography (PET/CT) images, lactate dehydrogenase (LDH) levels, and body mass index (BMI) before and after treatment were collected. Regions with a high standardized uptake value (SUV) in epicardial and orbital adipose tissue were selected and analyzed by a PET/CT viewer. The initial measurements and changes in the high SUV of epicardial and orbital adipose tissues, LDH levels, and BMI of treatment responders and non-responders, and complete and partial responders, were compared. Results: The volumes of high-SUV epicardial and orbital adipose tissues significantly increased in responders after R-CHOP (p = 0.03 and 0.002, respectively). There were significant differences between changes in the high-SUV volumes of epicardial and orbital adipose tissues (p = 0.03 and 0.001, respectively) and LDH levels (p = 0.03) between responders and non-responders. The changes in high-SUV epicardial adipose tissue volumes were greater among complete responders than partial responders (p = 0.04). Poorer treatment responses were observed in patients with lower high-SUV epicardial adipose tissue volumes and higher LDH levels after R-CHOP (p = 0.03 and 0.03, respectively). Conclusions: The preliminary results of greater changes in high-SUV epicardial and orbital adipose tissue volumes among responders indicate that brown adipose tissue could be considered a favorable prognostic biomarker.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) conducted an observational in Non-Hodgkin's lymphoma (n=20). R-CHOP treatment response vs. Non-responders was evaluated on Changes in high-SUV volumes of epicardial and orbital adipose tissues (p=0.03 and 0.001). Treatment responders to R-CHOP had greater increases in high-SUV epicardial and orbital adipose tissue volumes compared to non-responders.
Synapse has enriched 10 related papers. Consider them for comparative context: